摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

7-Chlor-1-cyclopropyl-6-nitro-1,4-dihydro-4-oxo-3-chinolincarbonsaeure | 93107-29-0

中文名称
——
中文别名
——
英文名称
7-Chlor-1-cyclopropyl-6-nitro-1,4-dihydro-4-oxo-3-chinolincarbonsaeure
英文别名
1-cyclopropyl-6-nitro-4-oxo-7-chloro-1,4-dihydroquinoline-3-carboxylic acid;7-chloro-1-cyclopropyl-1,4-dihydro-6-nitro-4-oxoquinoline-3-carboxylic acid;7-Chloro-1-cyclopropyl-6-nitro-1,4-dihydro-4-oxo-3-quinolinecarboxylic acid;7-chloro-1-cyclopropyl-1,4-dihydro-6-nitro-4-oxo-3-quinolinecarboxylic acid;7-chloro-1-cyclopropyl-6-nitro-4-oxoquinoline-3-carboxylic acid
7-Chlor-1-cyclopropyl-6-nitro-1,4-dihydro-4-oxo-3-chinolincarbonsaeure化学式
CAS
93107-29-0
化学式
C13H9ClN2O5
mdl
——
分子量
308.678
InChiKey
SSZUMRRPCBEXRX-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 熔点:
    249 °C
  • 沸点:
    542.6±50.0 °C(Predicted)
  • 密度:
    1.733±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    2.1
  • 重原子数:
    21
  • 可旋转键数:
    2
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.23
  • 拓扑面积:
    103
  • 氢给体数:
    1
  • 氢受体数:
    6

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量
    • 1
    • 2

反应信息

点击查看最新优质反应信息

文献信息

  • Microbicidal agents based on quinolonecarboxylic acid
    申请人:Bayer Aktiengesellschaft
    公开号:US04563459A1
    公开(公告)日:1986-01-07
    Combating microorganisms, particularly in agriculture, with a 1-cyclopropyl-1,4-dihydro-4-oxo-quinolinecarboxylic acid of the formula ##STR1## in which R.sup.1 is hydrogen, fluorine, chlorine, bromine or nitro, R.sup.2 is hydrogen, chlorine, fluorine or the group ##STR2## particularly a 4-piperazinyl radical, or an acid addition, alkali metal, alkaline earth metal or heavy metal salt thereof which is tolerated by plants, or a hydrate thereof. Some of the compounds are known.
    使用公式##STR1##中的1-环丙基-1,4-二氢-4-氧基-喹啉羧酸,特别是在农业中,与微生物作斗争,其中R.sup.1是氢、或硝基,R.sup.2是氢、或基团##STR2##,特别是4-哌嗪基基团,或其酸加合物、碱属、碱土属或植物耐受的重属盐,或其合物。其中一些化合物是已知的。
  • Quinolonecarboxylic acids and antibacterial agents containing these
    申请人:Bayer Aktiengesellschaft
    公开号:US04559341A1
    公开(公告)日:1985-12-17
    The invention relates to quinolone carboxylic acids, pharmaceutical compositions containing said quinolone carboxylic acids and the use of said compounds and compositions for treatment of bacterial infection. Also included in the invention are process for the manufacture of the active quinolone carboxylic acids.
    这项发明涉及喹诺酮羧酸、含有该喹诺酮羧酸的药物组合物以及利用该化合物和组合物治疗细菌感染的用途。该发明还包括制造活性喹诺酮羧酸的方法。
  • Bactericidal agents
    申请人:Bayer Aktiengesellschaft
    公开号:US04563448A1
    公开(公告)日:1986-01-07
    A method of combating plant-pathogenic bacteria, comprising applying to the bacteria or to a bacteria habitat a bactericidally effective amount of a cyclopropyl-1,4-dihydro-4-oxo-3-quinolinecarboxylic acid derivative of the formula ##STR1## in which A represents straight-chain or branched alkylene with 1 to 6 carbon atoms or a >C.dbd.CH-- radical, R.sup.1 represents alkoxycarbonyl with 1 to 6 carbon atoms in the alkyl part, benzyloxycarbonyl, carboxyl, optionally substituted carbamoyl, cyano or dialkoxyphosphonyl or alkylsulphonyl with 1 to 4 carbon atoms in the alkyl part, and R.sup.2 represents hydrogen, alkoxycarbonyl with 1 to 6 carbon atoms in the alkyl part, benzyloxycarbonyl, optionally substituted carbamoyl, cyano, chlorine, acetyl, alkyl with 1 to 3 carbon atoms or phenyl, or R.sup.1 and R.sup.2, together with the carbon atom which they substitute, can also form a 2-oxo-tetrahydrofuryl ring, R.sup.3, R.sup.4, R.sup.5 and R.sup.6 can be identical or different and represent hydrogen, methyl, ethyl or n- or i-propyl and X represents hydrogen, halogen or nitro, or an acid addition salt, alkali metal salt, alkaline earth metal salt, heavy metal salt or hydrate thereof. The heavy metal salts are new.
    一种对抗植物病原细菌的方法,包括向细菌或细菌栖息地施加有效杀菌作用的环丙基-1,4-二氢-4-氧-3-喹啉羧酸生物,其化学结构如下:其中A代表直链或支链烷基,含有1至6个碳原子,或>C=CH-基团,R1代表含有1至6个碳原子的烷基部分的烷氧羰基,苄氧羰基,羧基,可选择性取代的基甲酰基,基或含有1至4个碳原子的烷基磺酰基,R2代表氢,含有1至6个碳原子的烷基部分的烷氧羰基,苄氧羰基,可选择性取代的基甲酰基,基,,乙酰基,含有1至3个碳原子的烷基或苯基,或R1和R2,连同它们替代的碳原子,也可以形成2-氧代-四氢呋喃基环,R3,R4,R5和R6可以相同或不同,并且代表氢,甲基,乙基或n-或i-丙基,X代表氢,卤素或硝基,或其酸加合物盐,碱属盐,碱土属盐,重属盐或合物。这些重属盐是新的。
  • Quinolone acids and antibacterial agents containing these compounds
    申请人:Bayer Aktiengesellschaft
    公开号:US04559342A1
    公开(公告)日:1985-12-17
    The invention relates to quinolone carboxylic acids of the formula (I) as defined herein, pharmaceutical compositions containing said quinolone carboxylic acids and the use of said compounds and compositions for treatment of bacterial infection. Also included in the invention are process for the manufacture of the active quinolone carboxylic acids.
    该发明涉及到以下定义的式(I)的喹诺酮羧酸,含有该喹诺酮羧酸的药物组合物,以及用于治疗细菌感染的该化合物和组合物的用途。该发明还包括制造活性喹诺酮羧酸的工艺。
  • Adenine Modification at C7 as a Viable Strategy to Potentiate the Antimalarial Activity of Quinolones
    作者:Jais Kurian、Varsha Kumari、Saheer V. Chaluvalappil、Mohammad Anas、Ashan Manhas、Ramshad Kalluruttimmal、Niti Kumar、Muraleedharan K. Manheri
    DOI:10.1002/cmdc.202100472
    日期:2022.1.19
    A notable improvement in antimalarial potency on introducing an adenine moiety at the C7 position of quinolones is discussed. Advantages such as improved solubility, lower crystallinity, and a possible role in target binding, as revealed by docking analysis, makes adenine modification an attractive lead-optimization strategy. The ability of some of the potent compounds to disrupt mitochondrial function
    讨论了在喹诺酮类药物的 C7 位引入腺嘌呤部分后抗疟效力的显着改善。正如对接分析所揭示的那样,诸如提高溶解度、降低结晶度和可能在靶标结合中发挥作用等优点使腺嘌呤修饰成为一种有吸引力的先导优化策略。还证明了一些有效化合物破坏线粒体功能的能力。
查看更多